Exactech Equinoxe Small Reverse Shoulder Glenospheres , Exactech Equinoxe Reverse Shoulder Humeral Liners , Exactech Equinoxe Small Reverse Shoulder Glenoid Plates , Exactech Equinoxe Reverse Shoulder Locking Cap

K182536 · Exactech, Inc. · PHX · Oct 12, 2018 · Orthopedic

Device Facts

• Record ID: K182536
• Device Name: Exactech Equinoxe Small Reverse Shoulder Glenospheres , Exactech Equinoxe Reverse Shoulder Humeral Liners , Exactech Equinoxe Small Reverse Shoulder Glenoid Plates , Exactech Equinoxe Reverse Shoulder Locking Cap
• Applicant: Exactech, Inc.
• Product Code: PHX · Orthopedic
• Decision Date: Oct 12, 2018
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 888.3660
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Equinoxe Reverse Shoulder System is indicated for use in skeletally mature individuals with degenerative diseases of the glenohumeral joint and a grossly deficient, irreparable rotator cuff. The Equinoxe Reverse Shoulder is also indicated for a failed glenohumeral joint replacement with loss of rotator cuff function resulting in superior migration of the humeral head.

Device Story

The Exactech Equinoxe Small Reverse Shoulder is a subsystem for reverse total shoulder arthroplasty. It consists of small reverse glenoid plates, small reverse glenospheres, humeral liners, and locking caps. The device is used by orthopedic surgeons in a clinical/surgical setting to replace the shoulder joint. It functions as a semi-constrained prosthesis to restore joint function in patients with rotator cuff deficiency. The current submission introduces minor geometry modifications to the glenospheres and humeral liners, and adds compatibility between the locking cap and the small reverse glenoid plates/glenospheres. The device is implanted to provide stability and mobility in the shoulder joint, benefiting patients suffering from degenerative joint disease and rotator cuff failure.

Clinical Evidence

Bench testing only. Engineering and tolerance analyses (TM-2018-0755, TR-2018-0720, TM-2018-0523) were performed to evaluate mechanical and dimensional properties. Pyrogen testing was conducted in accordance with USP <161>, USP <85>, and ANSI/AAMI ST72.

Technological Characteristics

The device is a semi-constrained metal/polymer shoulder prosthesis. It utilizes the same materials and fundamental scientific technology as the predicate devices. Components include glenoid plates, glenospheres, humeral liners, and locking caps. Sterility is maintained per FDA guidance; pyrogen testing follows USP <161>, USP <85>, and ANSI/AAMI ST72 standards.

Indications for Use

Indicated for skeletally mature individuals with degenerative glenohumeral joint disease and grossly deficient, irreparable rotator cuff, or failed glenohumeral joint replacement with rotator cuff loss and superior humeral head migration.

Regulatory Classification

Identification

A shoulder joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a shoulder joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a humeral resurfacing component made of alloys, such as cobalt-chromium-molybdenum, and a glenoid resurfacing component made of ultra-high molecular weight polyethylene, and is limited to those prostheses intended for use with bone cement (§ 888.3027).

Special Controls

*Classification.* Class II. The special controls for this device are:(1) FDA's: (i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ” (ii) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),” (iii) “Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement,” (iv) “Guidance Document for the Preparation of Premarket Notification (510(k)) Application for Orthopedic Devices,” and (v) “Guidance Document for Testing Non-articulating, ‘Mechanically Locked’ Modular Implant Components,” (2) International Organization for Standardization's (ISO): (i) ISO 5832-3:1996 “Implants for Surgery—Metallic Materials—Part 3: Wrought Titanium 6-aluminum 4-vandium Alloy,” (ii) ISO 5832-4:1996 “Implants for Surgery—Metallic Materials—Part 4: Cobalt-chromium-molybdenum casting alloy,” (iii) ISO 5832-12:1996 “Implants for Surgery—Metallic Materials—Part 12: Wrought Cobalt-chromium-molybdenum alloy,” (iv) ISO 5833:1992 “Implants for Surgery—Acrylic Resin Cements,” (v) ISO 5834-2:1998 “Implants for Surgery—Ultra-high Molecular Weight Polyethylene—Part 2: Moulded Forms,” (vi) ISO 6018:1987 “Orthopaedic Implants—General Requirements for Marking, Packaging, and Labeling,” and (vii) ISO 9001:1994 “Quality Systems—Model for Quality Assurance in Design/Development, Production, Installation, and Servicing,” and (3) American Society for Testing and Materials': (i) F 75-92 “Specification for Cast Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implant Material,” (ii) F 648-98 “Specification for Ultra-High-Molecular-Weight Polyethylene Powder and Fabricated Form for Surgical Implants,” (iii) F 799-96 “Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants,” (iv) F 1044-95 “Test Method for Shear Testing of Porous Metal Coatings,” (v) F 1108-97 “Specification for Titanium-6 Aluminum-4 Vanadium Alloy Castings for Surgical Implants,” (vi) F 1147-95 “Test Method for Tension Testing of Porous Metal,” (vii) F 1378-97 “Standard Specification for Shoulder Prosthesis,” and (viii) F 1537-94 “Specification for Wrought Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implants.”

Predicate Devices

• Equinoxe Small Reverse Shoulder System (K180632)
• Equinoxe Reverse Shoulder (K063569)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

October 12, 2018

Exactech, Inc. Zach Sharrah Senior Regulatory Affairs Specialist 2320 NW 66th Court Gainesville, Florida 32653

Re: K182536

Trade/Device Name: Exactech Equinoxe Small Reverse Shoulder Glenospheres , Exactech Equinoxe Reverse Shoulder Humeral Liners , Exactech Equinoxe Small Reverse Shoulder Glenoid Plates , Exactech Equinoxe Reverse Shoulder Locking Cap Regulation Number: 21 CFR 888.3660 Regulation Name: Shoulder Joint Metal/Polymer Semi-Constrained Cemented Prosthesis Regulatory Class: Class II Product Code: PHX, KWT, KWT, KWS Dated: September 13, 2018 Received: September 14, 2018

Dear Zach Sharrah:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

| Vesa<br>Vuniqi -S | Digitally signed<br>by Vesa Vuniqi -S<br>Date: 2018.10.12<br>15:21:00 -04'00' |
|-------------------|-------------------------------------------------------------------------------|
|-------------------|-------------------------------------------------------------------------------|

Mark N. Melkerson For: Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K182536

Device Name

Exactech® Equinoxe® Small Reverse Glenospheres and Humeral Liners

#### Indications for Use (Describe)

The Equinoxe Reverse Shoulder System is indicated for use in skeletally mature individuals with degenerative diseases of the glenohumeral joint and a grossly deficient, irreparable rotator cuff. The Equinoxe Reverse Shoulder is also indicated for a failed glenohumeral joint replacement with loss of rotator cuff function resulting in superior migration of the humeral head.

Type of Use (Select one or both, as applicable)

| <div> <span> <span style="font-size: 16px;">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) </span> </div> |
|----------------------------------------------------------------------------------------------------------------------------------|
| <div> <span> <span style="font-size: 16px;">☐</span> Over-The-Counter Use (21 CFR 801 Subpart C) </span> </div> |

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

### Exactech® Equinoxe® Small Reverse Glenospheres and Humeral Liners Special 510(k) - 510(k) Summary of Safety and Effectiveness

| Sponsor: | Exactech®, Inc.<br>2320 NW 66th Court<br>Gainesville FL, 32653 |
|-------------------|----------------------------------------------------------------------------------------------------------|
| | Phone: [phone]<br>Fax: [phone] |
| | FDA Establishment Number 1038671 |
| Contact Person: | Zach Sharrah<br>Senior Regulatory Affairs Specialist<br>Telephone: [phone]<br>Fax: [phone] |
| Date: | September 13, 2018 |
| Proprietary Name: | Exactech® Equinoxe® Small Reverse Glenospheres and<br>Humeral Liners |
| Common Name: | Reverse Shoulder Arthroplasty |

### Classification Name:

- Shoulder Prosthesis, Reverse Configuration (21 CFR Section 888.3660, Class II, Product Code PHX
- Prosthesis, Shoulder, Non-Constrained, Metal/Polymer cemented (21 CFR ● Section 888.3650, Class II, Product Code KWT
- Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer cemented (21 ● CFR Section 888.3660, Class II, Product Code KWS

### Legally Marketed Device to Which Substantial Equivalence Is Claimed:

| Name | Manufacturer | 510(k) Number |
|----------------------------------------|----------------|---------------|
| Equinoxe Small Reverse Shoulder System | Exactech, Inc. | K180632 |
| Equinoxe Reverse Shoulder | Exactech, Inc. | K063569 |

### Indications for Use:

The Equinoxe Reverse Shoulder System is indicated for use in skeletally mature individuals with degenerative diseases of the glenohumeral joint and a grossly deficient, irreparable rotator cuff. The Equinoxe Reverse Shoulder is also indicated for a failed glenohumeral joint replacement with loss of rotator cuff function resulting in superior migration of the humeral head.

{4}------------------------------------------------

## Exactech® Equinoxe® Small Reverse Glenospheres and Humeral Liners Special 510(k) - 510(k) Summary of Safety and Effectiveness

### Device Description:

The Exactech Equinoxe Small Reverse Shoulder is a subsystem of the Exactech Equinoxe Reverse Shoulder System which provides small reverse glenoid plates, small reverse glenospheres, screw components, humeral liners, and surgical instrumentation for use in reverse total shoulder arthroplasty. The modifications proposed by this submission describe minor geometry changes to the predicate Exactech Equinoxe Small Reverse Shoulder Glenospheres and Humeral Liners. As well as minor geometry modifications, this submission proposes Equinoxe Locking Cap compatibility with the Small Reverse Glenoid Plates and Small Reverse Glenospheres.

Both the proposed and predicate devices share the following similarities:

- Identical Indications for Use ●
- 0 Identical intended use
- Identical device materials ●
- The same design features and basic fundamental scientific technology ●
- The same implant and instrument compatibility o

## Non-Clinical Testing:

Engineering and tolerance analyses were conducted to evaluate the mechanical and dimensional properties of the Exactech Equinoxe Small Reverse Glenospheres and Equinoxe Locking Cap compatibility:

- TM-2018-0755 - Justification for the Equinoxe Small Reverse Shoulder Glenosphere Internal Bore Modification and Standard Locking Cap Compatibility
- TR-2018-0720 Equinoxe Small Reverse Shoulder Glenosphere, ● Glenosphere Trial, and Locking Cap Tolerance Analysis
- TM-2018-0523 Justification for the Humeral Liner Undercut Geometry ● Tolerance Update

Pyrogen testing was conducted in accordance with USP <161>, USP <85>, and ANSI/AAMI ST72 to ensure the proposed Equinoxe Small Reverse Shoulder components meet recommended limits per FDA's Guidance Document Submission and Review of Sterility Information in Premarket (510(k)) Submission for Devices Labeled as Sterile.

## Substantial Equivalence Conclusion:

Results of the engineering analyses referenced in this 510(k) submission demonstrate the proposed Equinoxe Small Reverse Glenosphere and Humeral Liner devices are substantially equivalent to the cited cleared predicate Equinoxe Small Reverse Glenosphere and Humeral Liner devices.